SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Biskobing DM, Rubin J 1993 1,25-Dihydroxyvitamin D3 and phorbol myristate acetate produce divergent phenotypes in a monomyelocytic cell line. Endocrinology 132:862866.
  • 2
    Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Rieman D, Barthlow R, Hastings G, Gowen M 1996 Cathepsin K, but not cathepsins B, L, or S is abundantly expressed in human osteoclasts. J Biol Chem 271:1251112516.
  • 3
    Hallen JM, Raisanen S, Salo JJ, Reddy SV, Roodman GD, Hentunen TA, Lehenkari PP, Kaija H, Vihko P, Vaananen HK 1999 Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase. J Biol Chem 274:2290722910.
  • 4
    Hentunen TA, Reddy SV, Boyce BF, Devlin R, Park HR, Chung H, Selander KS, Dallas M, Kurihara N, Galson DL, Goldring SR, Koop BA, Windle JJ, Roodman GD 1998 Immortalization of osteoclast precursors by targeting Bcl-XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice. J Clin Invest 102:8897.
  • 5
    Huovila APJ, Almeida EA, White JM 1996 ADAMs and cell fusion. Curr Opin Cell Biol 8:692699.
  • 6
    Wolfsberg TG, Primakoff P, Myles DG, White JM 1995 ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: Multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol 131:275278.
  • 7
    Wu E, Croucher PI, McKie N 1997 Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of hematological malignancies. Biochem Biophys Res Commun 235:437442.
  • 8
    Bohm BB, Aigner T, Gehrsitz A, Blobel CP, Kalden JR, Burkhardt H 1999 Upregulation of MDC15 (metargidin) messenger RNA in human osteoarthritic cartilage. Arthritis Rheum 42:19461950.
  • 9
    Yoshiyama K, Higuchi Y, Kataoka M, Matsuura K, Yamamoto S 1997 CD156 (human ADAM8): Expression, primary amino acid sequence, and gene location. Genomics 41:5662.
  • 10
    Hentunen TA, Jackson SH, Chung H, Reddy SV, Lorenzo J, Choi SJ, Roodman GD 1999 Characterization of immortalized osteoclast precursors developed from mice transgenic for both bcl-XL and simian virus 40 large T antigen. Endocrinology 140:29542961.
  • 11
    Choi SJ, Devlin RD, Reddy SV, Chung H, Boyce BF, Roodman GD 1999 Identification of human asparaginyl endopeptidase (legumain) as an autocrine inhibitor of osteoclast formation and bone resorption. J Biol Chem 274:2774727753.
  • 12
    Choi SJ, Devlin RD, Menaa C, Chung H, Roodman GD, Reddy SV 1998 Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption. J Clin Invest 102:13601368.
  • 13
    Yates AJ, Oreffo RO, Mayor K, Mundy GR 1991 Inhibition of bone resorption by inorganic phosphate is mediated by both reduced osteoclast formation and decreased activity of mature osteoclasts. J Bone Miner Res 6:473478.
  • 14
    Sato T, Abe E, Jin CH, Hong MH, Katagiri T, Kinoshita T, Amizuka N, Ozawa H, Suda T 1993 The biological roles of the third component of complement in osteoclast formation. Endocrinology 133:397404.
  • 15
    Kukita T, Nomiyama H, Ohmoto Y, Kukita A, Shuto T, Hotokebuchi T, Sugioka Y, Miura R, Iijima T 1997 Macrophage inflammatory protein-1 alpha (LD78) expressed in human bone marrow: Its role in regulation of hematopoiesis and osteoclast recruitment. Lab Invest 76:399406.
  • 16
    Miyazaki T, Katagiri H, Kanegae Y, Takayanagi H, Sawada Y, Yamamoto A, Pando MP, Asano T, Verma IM, Oda H, Nakamura K, Tanaka S 2000 Reciprocal role of ERK, and NF-kappaB pathways in survival and activation of osteoclasts. J Cell Biol 148:333342.
  • 17
    Wolfsberg TG, Straight PD, Gerena RL, Huovila AP, Primakoff P, Myles DG, White JM 1995 ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev Biol 169:378383.
  • 18
    Weskamp G, Kratzschmar J, Reid MS, Blobel CP 1996 MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains. J Cell Biol 132:717726.
  • 19
    Lum L, Reid MS, Blobel CP 1998 Intracellular maturation of the mouse metalloprotease disintegrin MDC15. J Biol Chem 273:2623626247.
  • 20
    Cerretti DP, Poindexter K, Castner BJ, Means G, Copeland NG, Gilbert DJ, Jenkins NA, Black RA, Nelson N 1999 Characterization of the cDNA and gene for mouse tumor necrosis factor alpha converting enzyme (TACE/ADAM17) and its location to mouse chromosome 12 and human chromosome 2p25. Cytokine 11:541551.
  • 21
    Lum L, Wong BR, Josien R, Becherer JD, Erdjument-Bromage H, Schlondorff J, Tempst P, Choi Y, Blobel CP 1999 Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem 274:1361313618.
  • 22
    Karadag A, Zhou M, Edwards T, Holen I, Russell RG, Croucher PI 1998 The disintegrin domain of ADAM9 (a disintegrin and metalloprotease) promotes the production of interleukin-6 (IL-6) by human osteoblasts: Evidence for an interaction with the alpha-v integrin. J Bone Miner Res 13:S1;S537.(abstract)